4//SEC Filing
Jones Michael L 4
Accession 0001127602-21-011668
CIK 0000882796other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:19 PM ET
Size
6.3 KB
Accession
0001127602-21-011668
Insider Transaction Report
Form 4
Jones Michael L
Exec. Director, Finance - PAO
Transactions
- Exercise/Conversion
Common Stock
2021-03-18$3.51/sh+4,500$15,795→ 5,348 total - Exercise/Conversion
Emp. Stock Option (Right to Buy)
2021-03-18−4,500→ 0 totalExercise: $3.51From: 2012-03-21Exp: 2021-03-21→ Common Stock (4,500 underlying)
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001800060
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 4:19 PM ET
- Size
- 6.3 KB